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The MAP Kinase Pathway Controls Differentiation
from Double-Negative to Double-Positive Thymocyte
Tessa Crompton, Kimberly C. Gilmour, Results
and Michael J. Owen
Imperial Cancer Research Fund Retrovirus-Mediated Gene Transfer in Murine
Fetal Thymus Organ Culture44 Lincoln’s Inn Fields
London WC2A 3PX To assess the role of the MAP kinase cascade in the
development of immature thymocytes, we developed aUnited Kingdom
system for retrovirus-mediated expression of mutated
forms of components of this pathway in fetal thymus
organ culture (FTOC). In other hematopoietic lineages,
retroviruses have been shown to infect the earliest divid-Summary
ing progenitor cells and have been used to define the
developmental behavior of stem cells (Jordan et al.,T cell development is regulated at two major control
1990). Mutated MAP kinase kinase 1 (MAPKK1) mole-points where maturation, proliferation, and antigen re-
cules were expressed using this system. MAPKK1 regu-ceptor gene rearrangement are coordinated. Progres-
lates the activity of the MAP kinases, extracellular sig-sion through these developmental control points is
nal–regulated protein kinase 1 (ERK1) and ERK2, bothdependent upon the expression of different forms of
of which are expressed in T lymphocytes and are stimu-the T cell receptor. Here we show that the MAP kinase
lated by the p21ras pathway in response to TCR triggeringcascade is a regulator of the differentiation of imma-
(reviewed by Pastor et al., 1995). MAPKK1 mutants wereture thymocytes from double-negative to double-posi-
expressed in FTOC using thymic lobes from mice withtive cell, most probably acting as a transducer of pre-T
a disrupted TCRa gene (Philpott et al., 1992). TCRa-cell receptor signaling. Furthermore, this study dem-
deficient mice were used to limit possible CD3-mediatedonstrates the use of retrovirus-mediated gene transfer
signaling to the pre-TCR and not the mature ab TCR.in fetal thymic organ culture in the analysis of thymic
Retroviruses infect dividing cells, and since T cell pro-development in mutant mice, an alternative to trans-
genitors are proliferating very rapidly during early em-genesis by oocyte injection.
bryonic development (Kingston et al., 1985) and dou-
bling in numbers in less than 1 day, one would expect
a high frequency of infection. Analysis of the expressionIntroduction
of a cell surface reporter gene indicated that the effi-
ciency of infection was in excess of 80% of thymocytes.T cell development involves a tightly regulated series of
The constitutively active mutant of MAPKK1 used inproliferation and maturation events that are controlled,
this study, in which serine residues 217 and 221 wereat least in part, by different forms of the T cell receptor
both mutated to glutamic acid, has previously been(TCR) (reviewed by von Boehmer 1995). The transition
shown to stimulate growth factor–induced neurite out-from CD4282 double-negative (DN) to CD4181 double-
growth of PC12 pheochromocytoma cells and prolifera-positive (DP) thymocyte is dependent on the production
tion of NIH 3T3 fibroblasts (Alessi et al., 1994; Cowleyof a TCRb chain (Mombaerts et al., 1992a; Mallick et al.,
et al., 1994; Marshall 1994). In contrast, the dominant-1993; Shinkai et al., 1993) that is expressed at the cell
negative mutants used, in which one or other serine wassurface as the pre-TCR complex in conjunction with
mutated toalanine, inhibited both these functions (Alessithe CD3 polypeptides and the surrogate a chain, pTa
et al., 1994; Cowley et al., 1994). The constitutivelyactive(Groettrup et al., 1993; Saint-Ruf et al., 1994; Fehling et
MAPKK1 mutant and the two dominant-negative mu-al., 1995). In thymocytes that have generated an in-
tants were expressed in FTOC using the retroviral vectorframe VDJ rearrangement at the TCRb locus, there is a
pBABE puro (Cowley et al., 1994; Morgenstern andcessation of further TCRb rearrangement (Levelt et al.,
Land, 1990). Both dominant-negative mutations gave1995), a down-regulation of CD25 expression, an induc-
the same phenotype, and we observed noadditive effecttion of CD4 and CD8 coreceptor expression, and exten-
when they were used together. All data shown are forsive cellular proliferation.
the Ser-217 mutation.The intracellular signaling pathways activated at this
key transition during thymocyte development are not
well understood. It has been shown that the Src family MAPKK1 Mutants in TCRa2/2 FTOC
protein tyrosine kinase, p56lck, is required for efficient TCRa-deficient fetal thymus lobes were dissected on
progression from DN to DP thymocyte (Anderson et al., embryonic day 13 (E13) and incubated for 40 hr in Tera-
1994; Mombaerts et al., 1994; Molina et al., 1992; Wal- saki wells with adherent packaging cells containing the
lace et al., 1995). Here we show that the mitogen-acti- mutant molecules in the retroviral vector or the empty
vated protein (MAP) kinase cascade is activated upon retroviral vector alone. Lobes were then transferred to
CD3 ligation of immature CD251 thymocytes. We use a Millipore filters and cultured.
novel technique that combines retrovirus-mediated To confirm that the thymocytes had been infected by
gene transfer and fetal thymus organ culture to demon- the retrovirus containing the mutant MAPKK1 molecules
strate that the MAP kinase cascade is required for differ- and that the mutant molecules were influencing the acti-
vation of the MAP kinase cascade, we performed myelinentiation of immature thymocytes from DN to DP cell.
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Figure 1. Retrovirus Containing the Dominant-Negative MAPKK1
Construct Inhibits MAP Kinase Activity in Infected FTOC, while Ret-
rovirus Containing the Constitutively Active MAPKK1 Construct In-
duces MAP Kinase Activity in Infected FTOC
E13 thymi were isolated and infected with retroviruses, and FTOCs
were established as described in Experimental Procedures. After 4
days of culture, thymi were lysed and an MBP kinase assay was
performed. Phosphorylated MBP is indicated. Lane 1, dominant-
negative (DN) MAP kinase construct; lane 2, empty vector (V); lane
3, constitutively active (CA) MAP kinase construct.
basic protein (MBP) in vitro kinase assays. MBP kinase
assays are a measure of the ability of activated MAP
kinase tophosphorylate an exogenous substrate, and as
such they directly measure the influence of the MAPKK1
mutants on MAP kinase activity (Alessi et al., 1995).
Thymocytes from theFTOC were lysed, and MBP assays
were performed. As demonstrated in Figure 1, thymo-
cytes from FTOC infected with the retrovirus containing
the dominant-negative MAPKK1 showed a 4-fold inhibi-
tion of MAP kinase activity relative to thymocytes in-
fected with the empty vector. In contrast, thymocytes
infected with the retrovirus containing the constitutively
active MAPKK1 had a 3-fold increase in MAP kinase
activity compared with thymocytes infected with the
empty vector. These results indicated that the proteins
encoded by these constructs were expressed and were
biochemically active in thymocytes from the FTOC. Figure 2. Flow Cytometric Analysis of E13 Fetal Thymus from TCRa-
On E13, before retroviral infection, all thymocytes Deficient Mice Prior to FTOC
lackedboth CD4 and CD8 expression, and only between
The upper panel shows CD4 and CD8b fluorescence, with the per-
25% and 30% of these cells had acquired expression centage of cells in each quadrant. The middle panel shows heat-
of CD25 (Figure 2). After 6 days, an increase in CD4 and stable antigen (HSA) and CD25 fluorescence, with the percentage
CD8expression was observed in lobes that had received of cells in each quadrant. The lower histogram shows CD25 fluores-
cence, with the percentage of cells expressing CD25. Approximatelythe retrovirus containing constitutively active MAPKK1,
104 thymocytes were harvested per lobe.butprogression to DP cells was inhibited in the presence
of the dominant-negative mutant (Figure 3A). More sin-
gle-positive (SP) thymocytes were observed in lobes
(Table 2). In addition, there was no difference in proteincultured with constitutively active MAPKK1 (Figure 3A;
levels recovered upon thymocyte lysis among the threeTable 1).These SP thymocytes appeared kinetically after
groups. Propidium iodide analysis of thecell cycle statusDP cells and did not express detectable levels of cell
of thymocytes recovered from the three experimentalsurface CD25, CD3, or gd TCR.
groups confirmed that introduction of the mutant mole-There was no significant increase in total thymocyte
cules did not affect proliferation (Figure 4A). In all threenumbers in the lobes that had received the constitutively
groups, although some increase in cell numbers hadactive MAPKK1 compared with the empty vector, sug-
occurred compared with the number of cells recoveredgesting that the constitutively active molecule had ac-
celerated differentiation without increasing proliferation from a thymocyte lobe dissected on E13 (approximately
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Figure 3. Flow Cytometric Analysis of CD4,
CD8, and CD25 Expression on TCRa2/2 FTOC
Infected with Retroviral Constructs
(A) shows flow cytometric analysis of FTOC
from TCRa-deficient mice. Thymi were in-
fected with retroviruses containing the
empty retroviral vector, dominant-negative
MAPKK1 (S217A mutation), and constitu-
tively active MAPKK1. Upper panels show
CD4 andCD8b immunofluorescence, with the
percentage of cells in each quadrant. Lower
panels show forward light scatter (FSC), with
the percentage of cells within the marker
shown.
(B) shows an analysis of CD25 expression in
thymocyte populations from retrovirus-in-
fected FTOC. CD25 staining is shown gated
on the total thymocyte population and on DN
and DP populations, corresponding to the
lower left and upper right quadrants shown in
(A). The percentage of cells within the marker
shown is given.
104 cells), the total number of thymocytes was consider- Comparison of cell size among the three groups
showed that the dominant-negative MAPKK1 mutantably less than would have been generated during the
same period in vivo. This reduction in cell yields com- arrested the development of thymocytes as large cells
(Figure 3A). This developmental block was reminiscentpared with the in vivo situation is a well-documented
limitation of FTOC (Jenkinson and Owen 1990), but may of that caused by recombinase-activating gene (RAG)
mutations (Mombaerts et al., 1992b; Shinkai et al., 1992)be exaggerated in our system by the 40 hr incubation
with the adherent packaging cell lines. Efficient thymo- and CD3e gene mutations (Malissen et al., 1995), in
which progression beyond the CD251 DN thymocytecyte differentiation, however, did occur, from a starting
population containing only early progenitor cells (Fig- stage was inhibited. Indeed, the percentage of CD25
expression in the DN thymocyte population was mark-ure 2) to all subsequent thymocyte subsets (Figure 3A;
Table 1). edly increased by dominant-negative MAPKK1 (Table
Table 1. Thymocyte Populations in TCRa-Deficient FTOC after 6 Days in Culture
Proportion (%)
Dominant-Negative Constitutively
Subpopulation Empty Vector MAPKK1 Active MAPKK1
CD4 SP 2.9 6 0.8 2.5 6 0.8 8.00 6 2.5
CD8 SP 2.8 6 1.5 2.00 6 0.5 5.7 6 3.0
CD251 31.1 6 7.6 59.3 6 5.6 26.5 6 3.5
Data are represented as mean 6 standard deviation of six experiments. In each experiment about 16 lobes were analyzed per group.
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Figure 4. Cell Cycle Analysis and CD44 Ex-
pression on TCRa2/2 FTOC Infected with Ret-
roviral Constructs
(A) Flow cytometric analysis of propidium io-
dide staining of permeabilized thymocytes.
Cells were isolated from FTOC infected with
retrovirus containing the empty vector, domi-
nant-negative MAPKK1, and constitutively
active MAPKK1. The percentage of cells fall-
ing within the markers is shown.
(B) Flow cytometric analysis of CD44 expres-
sion on thymocytes isolated from the three
groups of FTOC. CD44 expression is shown
for the whole thymus and gated on the CD251
DN population. The percentage of cells falling
within the markers is given.
1; Figure 3B). Although there was little difference in the
percentage of CD25 expression between the lobes cul-
Table 2. Cell Yield in TCRa- or RAG1-Deficient FTOC after 6 tured with the empty retroviral vector and the constitu-
Days in Culture tively active MAPKK1 (Table 1), the absolute number of
CD251 DP thymocytes increased in the presence of theFTOC Molecule Cell Recovery
active molecule (Figure 3B). Thus, expression of con-
TCRa2/2 Empty vector 4.1 6 1.2 3 104
stitutively active MAPKK1 apparently resulted in theTCRa2/2 Constitutively active MAPKK1 5.2 6 1.7 3 104
acquisition of CD4 and CD8 expression prior to CD25TCRa2/2 Dominant-negative MAPKK1 4.5 6 1.9 3 104
down-regulation. This pattern of CD25, CD4, and CD8RAG12/2 Empty vector 1.9 6 0.7 3 104
RAG12/2 Constitutively active MAPKK1 2.5 6 1.4 3 104 expression has also been observed in fetal thymic devel-
RAG12/2 Empty vector, anti-CD3 2.4 6 1.1 3 105 opment of CD3z-deficient mice, in which differentiation
RAG12/2 Dominant-negative 1.0 6 1.2 3 105 to DP cells occurs without normal cellular proliferation
MAPKK1, anti-CD3
(Crompton et al., 1994).
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Figure 5. Flow Cytometric Analysis of CD25
and CD44 Expression on E14.5 Thymocytes
from TCRa2/2 and RAG12/2 Mice
CD25 expression is shown for the whole thy-
mus and CD44 expression is shown gated on
the CD251 DN cells. The percentage of cells
falling within the marker is given.
Expression of the maturation marker CD44 also indi- versus 3.5-fold), v-Ha-ras was unable to drive differenti-
ation to DP thymocytes.cated that constitutivelyactive MAPKK1 accelerateddif-
ferentiation and the dominant-negative molecule ar- In contrast with the failure of constitutively active
MAPKK1 to generate DP thymocytes, incubation ofrested differentiation (Figure 4B). CD44 expression was
brighter on the CD251 DN cells in the presence of domi- RAG12/2 lobes with anti-CD3 monoclonal antibody
(MAb) resulted in efficient progression from the DN tonant-negative MAPKK1 (Figure 4B).This pattern of CD44
expression corresponded to that observed in CD3-defi- DP thymocyte (Levelt et al., 1993, 1995). Thus, when
RAG12/2 thymic lobes were incubated with anti-CD3cient mice (Crompton et al., 1994) and RAG1-deficient
mice (Figure 5) during fetal development. On E14.5 both MAb, a 250-fold increase in the number of DP thymo-
cytes was observed after the 6 day culture period (FigureTCRa2/2 and RAG12/2 thymocytes expressed equivalent
levels of CD25, but expression of CD44 on the CD251 6). In contrast, when lobes were incubated with antibody
in the presence of a retrovirus harboring a dominant-subset was brighter in the RAG12/2 thymocytes (Figure
5). Thus, the dominant-negative MAPKK1 blocked thy- negative MAPKK1 mutant, the development of DP thy-
mocytes was virtually abolished, and that of immaturemocyte development at the same stage as the arrest in
RAG12/2 mice. CD81 transitional cells (the immediate precursor of DP
thymocytes) was reduced more than 3-fold, as was pro-
liferation (Figure 6; Table 2). These data suggest thatMAPKK1 Mutants in RAG12/2 FTOC
These results show that activation of the MAP kinase the MAP kinase pathway is necessary for differentiation
from DN to DP thymocyte and that this cascade is acti-cascade is necessary for progression from DN to DP
thymocyte in fetal thymocyte development. To deter- vated through CD3-mediated signals.
mine whether activation of this pathway is sufficient to
drive this transition, we assessed the ability of constitu- Activation of MAP Kinase in RAG12/2
Thymocytes through CD3tively active MAPKK1 to induce progression from DN
to DP thymocyte in RAG1-deficient FTOC. Thymocyte To examine the activation of MAP kinase by CD3, we
isolated thymocytes from RAG12/2 mice, incubatedthemdevelopment is arrested at the CD251 DN thymocyte
stage in these mutant mice because of a failure to re- with anti-CD3 MAb, and performed MBP kinase as-
says. CD3 activation of MAP kinase was examined inarrange the TCRb locus and, consequently, to express
the pre-TCR (Mombaerts et al., 1992b; Shinkai et al., both adult thymocytes and thymocytes from neonatal
RAG12/2 mice. Figure 7A shows that CD3 ligation in-1992). When E13 thymic lobes from RAG12/2 mice were
incubated for 40 hr with a packaging line producing creases MAP kinase activity 3-fold in both neonatal and
adult RAG12/2 thymocytes. This result demonstratesretrovirus harboring a constitutively active MAPKK1
gene, followed by culture for 6 days, no significant in- that ligation of CD3 is sufficient for MAP kinase activa-
tion in immature CD251 DN thymocytes. The 3-fold in-crease in DP thymocytes was observed when compared
with lobes cultured with empty vector. However, an in- crease in ERK activation through CD3 on immature DN
thymocytes was equivalent to the activation observedcrease in the number of immature CD8 SP cells was
evident (Figure 6). when FTOCs were infected with retroviruses containing
the constitutively activeMAPKK1 constructs. In lympho-This experiment was repeated using a retrovirus con-
taining a constitutively active v-Ha-ras construct. MBP cyte and neuronal cell lines, a variety of agonists have
been shown to increase MAP kinase activity by 2- to 5-assays demonstrated that v-Ha-ras increased ERK acti-
vation in thymocytes 5.2-fold above the activation ob- fold, with maximum activation between 1 and 10 min
following treatment (Casillas et al., 1993; Cazaubon etserved in the presence of the empty vector. Despite
the higher levels of ERK activation induced by v-Ha-ras al., 1993). We examined the kinetics of MAP kinase acti-
vation by CD3 in RAG12/2 thymocytes. Thymocytes werecompared with constitutively active MAPKK1 (5.2-fold
Cell
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Figure 6. Flow Cytometric Analysis of FTOC
from RAG1-Deficient Mice
Thymi were infected with retroviruses con-
taining the empty vector, constitutively active
MAPKK1, and dominant-negative MAPKK1
and incubated with or without anti-CD3 MAb.
Thymocytes were analyzed for CD4 and CD8
expression.
isolated from adult RAG12/2 mice and left untreated or for differentiation from DN to DP thymocyte. Dominant-
treated with anti-CD3 MAb for 1 or 5 min at 378C. An negative MAPKK1 inhibited progression from DN to DP
MBP kinase assay was then performed (Figure 7B). An thymocyte in TCRa2/2 FTOC and inhibited anti-CD3-me-
average 3.5-fold increase in MBP activation was ob- diated thymocyte development in RAG12/2 FTOC. We
servedat 1 min. This was maximal, since at 5 min a 3-fold also show that ligation of CD3 on immature DN thymo-
increase in MAP kinase activity was observed. These cytes activates the MAP kinase cascade. CD3 cross-
kinetics indicate that MAP kinase is downstream of CD3 linking presumably mimicks the signal that is normally
on immature thymocytes and is a primary component transduced via the pre-TCR.
of this signaling pathway. The fetal thymus containsboth replicating thymocytes
and stromal cells, so it is formally possible that the
mutant molecules are exerting their effect indirectly viaDiscussion
stromal elements. We show, however, that retroviruses
containing these constructs affect MAP kinase activityWe describe the useof a novel technique involving retro-
in thymocytes from infected FTOC. In addition, givenvirus-mediated gene transfer into FTOC to demonstrate
that activation of the MAP kinase cascade is necessary that anti-CD3-induced thymocyte development oper-
Figure 7. Activation of MAP Kinase by Anti-
CD3 Antibody in RAG12/2 Mice
(A) An anti-CD3 antibody activates MAP ki-
nase in thymocytes from adult and neonatal
RAG12/2 mice. Thymocytes were isolated
from either neonatal (lanes 1 and 2) or adult
(lanes 3 and 4) RAG12/2 mice and left un-
treated (lanes 1 and 4) or were treated with
anti-CD3 antibody for 5 min (lanes 2 and 3),
and an MBP kinase assay was performed.
Phosphorylated MBP is indicated.
(B) An anti-CD3 antibody activates MAP ki-
nase activity in RAG12/2 mice within 1 min
of treatment. Thymocytes were isolated from
adult RAG12/2 mice and left untreated (lanes
1 and 3) or were treated with anti-CD3 for 1
(lanes 2) or 5 min (lane 4), and an MBP kinase
assay was performed. Phosphorylated MBP
is indicated.
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ates via a direct effect of the antibody on the DN thymo- at high levels prior to p56lck expression. In the p21ras
and MAPKK1 transgenic mice, the expression of thecyte and does not depend upon an interaction of the
dominant-negative molecules was itself controlled bypre-TCR with its putative ligand, the observation that
the p56lck promoter, and so they were presumably ex-the dominant-negative MAPKK1 inhibited anti-CD3-me-
pressed concomitantly with p56lck.diated differentiation in RAG12/2 FTOC supports the no-
Our data provide a possible explanation for the recenttion that the retroviruses exert their effects in an autono-
observation that irradiation can drive development frommous fashion on developing T lineage cells.
DN to DP thymocyte in RAG-deficient mice (Guidos etExperiments using p56lck mutants suggest that this
al., 1995). Activation of the MAP kinase pathway canprotein tyrosine kinase mediates both proliferation and
occur in response to irradiation (Sachsenmaier et al.,differentiation of immature thymocytes. Thus, both pro-
1994). Therefore it is possible that irradiation of RAG-cesses are affected in p56lck-deficient mice (Molina et
deficient mice directly activated MAPKK1. Alternatively,al., 1992; Wallace et al., 1995) and in dominant-negative
irradiation and other types of stress are known to acti-p56lck transgenic mice (Levin et al., 1993; Anderson et
vate the c-Jun N-terminal kinase (JNK) pathway (Kyriakisal., 1993), whereas constitutively active p56lck expressed
et al., 1994), which is involved in signal transduction inas a transgene can fully complement the DN to DP thy-
mature T cells (Su et al., 1994). It is possible that theremocyte transition in RAG-deficient mice (Mombaerts
is cross talk between MAP kinase and JNK pathwayset al., 1994). The failure of the constitutively active
and that activation of the JNK kinase pathway may acti-MAPKK1 to increase proliferation in TCRa-deficient
vate MAPKK1 (Cano and Mahadevan, 1995).FTOC during the culture period and to induce differentia-
In summary, this study demonstrates that early fetaltion from DN to DP in RAG12/2 FTOC suggests that
thymocyte development is coupled to the MAP kinaseactivation by the pre-TCR initiates multiple downstream
pathway. The ability of a dominant-negative MAPKK1signal transduction pathways.
mutant to inhibit anti-CD3-induced differentiation in aOur experiments demonstrate the role of the MAP
RAG12/2 thymus, and the direct demonstration of MAPkinase pathway in transmitting CD3-mediated signals in
kinase activation by CD3 ligation in thesemice, suggestsimmature DN thymocytes. In addition to its established
that this pathway operates downstream of the pre-TCR.role in transducing signals via the TCR in peripheral T
This conclusion is consistent with the common use ofcells (reviewed by Pastor et al., 1995), activation of the
the CD3 signal transduction module by both the ab TCRMAP kinase pathway has been shown to be necessary
and the bpTa TCR heterodimers. Given the evolutionaryfor positive selection of SP thymocytes. Thus, mice
conservation of the MAPK signal transduction pathwayexpressing a dominant-negative MAPKK1 or p21ras
(Dickson and Hafen 1994; Eisenmann and Kim 1994), ittransgene failed to select positively thymocytes ex-
would perhaps be surprising if unrelated signal path-pressing an H-Y-specific TCR (Alberola-Ila et al., 1995;
ways had evolved downstream of different conforma-Swan et al., 1995). Consistent with these studies, our
tions of the TCR.data indicate that expression of a constitutively active
MAPKK is sufficient to allow differentiation from DP to
Experimental ProceduresSP thymocyte in the absence of an ab TCR–mediated
signal.
MiceIn the dominant-negative MAPKK1 transgenic ani-
Mice were bred and maintained in the ICRF Biological Resources
mals, the differentiation of adult DN thymocytes was not Unit under specific pathogen–free conditions. TCRa-deficient mice
affected (Alberola-Ila et al., 1995). Although the reason were as described previously (Philpott et al., 1992), and RAG1-
deficient mice were obtained from the Jackson Laboratories. Timedfor this discrepancy is unknown, it is possible that inhibi-
matings were performed by mating one male with three femalestion of the DN to DP transition by dominant-negative
and monitoring females for plugs. The day the plug was found wasMAPKK1 is more easily detected in the TCRa-deficient
counted as E1.
mice and during fetal rather than adult T cell develop-
ment. Thus, there may be a qualitative difference in the Flow Cytometry and Antibodies
regulation of the DN to DP thymocyte transition between Individual lobes were harvested and stained using anti-CD25 FITC
(Pharmingen), anti-CD4pe (Pharmingen), or anti-HSApe (Pharmingen)fetal and adult development. Alternatively, it is possible
and anti-CD8b biotin (Pharmingen) or anti-CD8a biotin (Phar-that the dominant-negative MAPKK1 mutants used in
mingen), revealed with streptavidin–TRICOLOR (Caltag). In somethepresent study interfere more strongly at this develop-
cases, cells were stained using anti-CD44 FITC (Pharmingen), anti-
mental stage than the kinase-dead MAPKK1 mutant CD8a PE (Pharmingen), and anti-CD25 biotin (Pharmingen), revealed
used for the generation of transgenic mice. The domi- with streptavidin–TRICOLOR. Cell suspensions were stained with
nant-negative MAPKK1 mutant used here has been MAbs for 40 min at 48C in 100 ml of E4 medium containing 2%
FCS and 0.1% sodium azide. Cells were washed with this mediumshown tohave a stronger inhibitory effect onMAP kinase
between incubations and prior to analysis on a facscan (Bectonactivation in fibroblast cell lines than the kinase-dead
Dickinson). Events were collected in list mode using CellQuest soft-mutant used in the transgenic studies (C. Marshall, per-
ware (Becton Dickinson), and data were analyzed using CellQuest
sonal communication). The fact that, unlike the mutants software. Live cells were gated according to their FSC and SSC
used here, the kinase-dead form can still be phosphory- profiles. Data shown are representative of six experiments.
lated at both critical serine residues (Seger et al., 1994) Propidium lodide analysis of cell cycle status was as described
previously (Crompton et al., 1994). Events were collected and ana-may lead to a difference in substrate specificity and the
lyzed using a doublet discrimination module (Becton Dickinson).negative effect exerted on signal transduction. More-
over, the retroviral system is in principle more likely to
Constructs
be capable of blocking an early signal transmitted by Dominant-negative and constitutively active MAPKK1 (Alessi et al.,
p56lck because the dominant-negative molecules re- 1994; Cowley et al., 1994) were provided by Dr Chris Marshall in the
pBabe vector in the retroviral packaging cell line GP1E.quired to compete with that signal can be synthesized
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FTOC cellular proliferation: contrast with phorbol 12-myristate 13-acetate.
Biochem. J. 290, 545–550.Fetal thymi were dissected on E13 and incubated for 40 hr in Tera-
saki wells containing 20 ml of adherent retroviral packaging cells at Cazaubon, S., Parker, P.J., Strosberg, A.D., and Couraud, P.O.
1 3 105 cells per milliliter. Packaging cells were preincubated in the (1993). Endothelins stimulate tyrosine phosphorylation and activity
Terasaki wells for 2 days to achieve a viral titre in excess of 106 of p42/mitogen-activated protein kinase in astrocytes. Biochem. J.
particles per milliliter (H. Land, personal communication). Lobes 293, 381–386.
were transferred to Millipore filters and incubated for 6 days in Chung, J., Chen, R.-H., and Belnis, J. (1991). Coordinate regulation
defined medium (Jenkinson and Owen, 1990). of pp90rsk and a distinct protein-serine-threonine kinase activity that
To ascertain the efficiency of expression and that the transgenes phosphorylates recombinant pp90rsk in vitro. Mol. Cell Biol. 11, 1868–
were expressed at all developmental stages, we used the retroviral 1874.
system to introduce transgenic a and b chains of a TCR derived
Cowley, S., Paterson, H., Kemp, P., and Marshall, C.J. (1994). Activa-from a CTL clone using the Vb8.2 gene segment (Luescher et al.,
tion of map kinase kinase is necessary and sufficient for PC12 differ-1995). Three-color immunofluorescence using an antibody directed
entiation and for transformation of NIH 3T3 cells. Cell 77, 841–852.against Vb8.2 demonstrated that the transgenic TCR was expressed
Crompton, T., Moore, M., MacDonald, H.R., and Malissen, B. (1994).in over 80% of cells.
Double-negative thymocyte subsets in CD3-z chain-deficient mice:In experiments where anti-CD3 MAb was added to the culture
absence of HSA(1) CD44(2) CD25(2) cells. Eur. J. Immunol. 25,medium, purified 145-2C11 (Pharmingen) was used at a concentra-
1903–1907.tion of 25 mg/ml.
Dickson, B., and Hafen, E. (1994). Genetics of signal transduction
In Vitro MBP Kinase Assays in invertebrates. Curr. Opin. Genet. Dev. 4, 64–70.
Thymocytes were isolated and left untreated or treated with a biotin- Eisenmann, D.M., and Kim, S.K. (1994). Signal transduction and cell
conjugated anti-CD3 antibody (2C11; Pharmingen), cross-linked fate specification during Caenorhabditis elegans vulval develop-
with streptavidin (Caltag) for the indicated time, lysed in a 1% Triton ment. Curr. Opin. Genet. Dev. 4, 508–516.
lysis buffer (Gilmour and Reich, 1994), and normalized for protein
Fehling, H.J., Krotkova, A., Saintruf, C., and von Boehmer, H. (1995).levels. ERKs were immunoprecipitated with an anti-ERK1 antibody
Crucial role of the pre-T-cell receptor-a gene in development of ab(C-16; Santa Cruz Biotechnology), collected on protein A/G PLUS
but not gd T-cells. Nature 375, 795–798.agarose (Santa Cruz Biotechnology), washed three times with lysis
Gilmour, K.C., and Reich, N.C. (1994). Receptor to nucleus signallingbuffer, two times with 13 PBS plus 1 mM sodium vanadate, and
by prolactin and interleukin 2 via activation of latent DNA-bindingone time with kinase buffer (Chung et al., 1991). Protein kinase
factors. Proc. Natl. Acad. Sci. USA. 91, 6850–6854.assays were performed as described previously (Chung et al., 1991)
except that MBP (Sigma) was used as the substrate. g-ATP (3000 Groettrup, M., Ungewiss, K., Azogui, O., Palacios, R., Owen, M.J.,
Hayday, A.C., and von Boehmer, H. (1993). A novel disulfide-linkedCi/mMole) was purchased from DuPont New England Nuclear.
Phosphorylated MBP was quantified by phosphorimaging using a heterodimer on pre-T-cells consists of the T-cell receptor b chain
and a 33 kd glycoprotein. Cell 75, 283–294.PhosphorImager (Molecular Dynamics). The fold increase/decrease
in MBP phosphorylation is mean of the three experiments. Guidos, C.J., Williams, C.J., Wu, G.E., Paige, C.J., and Danska,
J.S. (1995). Development of CD4 (1) CD8 (1) thymocytes in RAG-
Acknowledgments deficient mice through a T-cell receptor-b chain-independent path-
way. J. Exp. Med. 181, 1187–1195.
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